A practical reference on thymosin beta-4: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-24 and is reviewed periodically as new material appears.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
Komodo dragons have long been sought-after zoo attractions, where their size and reputation make them popular exhibits. They are, however, rare in zoos because they are susceptible to infection and parasitic disease if captured from the wild, and do not readily reproduce in captivity. A pair of Komodo dragons was displayed at the Bronx Zoo in New York in September 1926, but they only lasted a couple of months, dying in October and November 1926. The first Komodo dragons were displayed at London Zoo in 1927. A Komodo dragon was exhibited in 1934 in the United States at the National Zoo in Washington, D.C., but it lived for only two years. More attempts to exhibit Komodo dragons were made, but the lifespan of the animals in captivity at the time proved very short, averaging five years in the National Zoological Park. Studies were done by Walter Auffenberg, which were documented in his book The Behavioral Ecology of the Komodo Monitor, eventually allowing for more successful management and breeding of the dragons in captivity. Surabaya Zoo in Indonesia has been breeding Komodo dragons since 1990 and had 134 dragons in 2022, the largest collection outside its natural habitat. As of May 2009, there were 35 North American, 13 European, one Singaporean, two African, and two Australian institutions which housed captive Komodo dragons. In 2016, four Komodo dragons were transferred from the Bronx Zoo to Madras Crocodile Bank Trust in India. A variety of behaviors have been observed from captive specimens.
Cob(I)alamin is oxidised to cob(II)alamin about once every 100 methyl transfer cycles, rendering the cob(I)alamin-MTR-enzyme complex inactive. Reactivation of this enzyme complex occurs through reductive remethylation by MTRR, utilizing S-adenosylmethionine as a methyl donor. MTR reactivation can also be NADPH dependent involving two redox proteins, soluble cytochrome b5 and reductase 1. However, this pathway is responsible for a minor role in reactivation, whilst MTRR remains a major contributor in this reductive reactivation. Biological processes influenced by MTRR include:
== Career == D'Abo made her screen debut in the low-budget science fiction horror film Xtro (1982), playing Analise Mercier, a French au pair, who becomes a human incubator for an alien. She appeared in the film Until September (1984) and had small roles in television mini-series based on Sidney Sheldon's novels Master of the Game (1984) and If Tomorrow Comes. She also appeared in Oscar winner Taylor Hackford's film White Nights (1985) and in an uncredited role as a woman pouring champagne to Klaus Maria Brandauer at a hunting party in the Oscar winning Out of Africa (1985), directed by Oscar winner Sydney Pollack. Other credits include Arthur the King (1985). She worked on the French stage in Lyon playing Varinia in Spartacus directed by Jacques Weber in 1981, played Roxane in Cyrano de Bergerac at the Grenier de Toulouse in 1982, then worked in a 1987 French TV movie, Les Idiots (The Idiots), written by Gérard Brach, with Jean Carmet and Jean-Pierre Marielle. D'Abo had a starring role in The Living Daylights (1987) as Kara Milovy, the sweet and vulnerable Czechoslovak cellist and would-be sniper who falls for James Bond. As a tie-in with the film, she also appeared in a Bond-themed Playboy cover and multi-page pictorial in the September 1987 issue, but later said in an interview with People magazine that "I wouldn't do those pictures now... I've learned a lot since then". She featured in the music video to the 1987 single 'So the Story Goes' by British band Living in a Box.
The fruit is an achene, similar to sunflower seed, with a single seed inside a hard outer hull. The starchy endosperm is white and makes up most or all of buckwheat flour. The seed coat is green or tan, which darkens buckwheat flour. The hull is dark brown or black, and some may be included in buckwheat flour as dark specks. The dark flour is known as blé noir (black wheat) in French, along with the name sarrasin (saracen). Similarly, in Italy, it is known as grano saraceno (saracen grain). Buckwheat pasta is made in various shapes in Italy as pasta di grano saraceno, and as the flat ribbons of pizzoccheri. Buckwheat groats are commonly used in eastern Europe to make a porridge called kasha, often considered the definitive peasant dish. Buckwheat noodles are used in Tibet and Nepal to make thukpa soup. Similar noodles play a major role in the cuisines of Japan (soba) and Korea (naengmyeon, makguksu and memil-guksu). Soba noodles are the subject of deep cultural importance in Japan. The difficulty of making noodles from flour with no gluten has resulted in a traditional art developed around their manufacture by hand. A jelly called memilmuk in Korea is made from buckwheat starch. Local buckwheat variety from Bongpyeong, Korea, is known as Bongpyeong memil and is a powerful symbol for both cultural and gastronomic reasons. Yeasted patties called hrechanyky are made in Ukraine, whereas across the border, in southeastern Poland hreczanyki are thick patties of ground pork mixed with cooked buckwheat groats (kasza gryczana).
Sources: en.wikipedia.org
Carbonaceous chondrites or C chondrites are a class of chondritic meteorites comprising at least 8 known groups and many ungrouped meteorites. They include some of the most primitive known meteorites. The C chondrites represent only a small proportion (4.6%) of meteorite falls. Some famous carbonaceous chondrites are: Allende, Murchison, Orgueil, Ivuna, Murray, Tagish Lake, Sutter's Mill, and Winchcombe.
This allows geochemists to spatially map the isotope composition in cross-sections of rock samples, a tool which is lost if the rock is digested and introduced as a liquid sample. Lasers for this task are built to have highly controllable power outputs and uniform radial power distributions, to produce craters which are flat bottomed and of a chosen diameter and depth. For both Laser Ablation and Desolvating Nebulisers, a small flow of nitrogen may also be introduced into the argon flow. Nitrogen exists as a dimer, so has more vibrational modes and is more efficient at receiving energy from the RF coil around the torch. Other methods of sample introduction are also utilized. Electrothermal vaporization (ETV) and in torch vaporization (ITV) use hot surfaces (graphite or metal, generally) to vaporize samples for introduction. These can use very small amounts of liquids, solids, or slurries. Other methods like vapor generation are also known.
TSH (with a half-life of about an hour) stimulates the thyroid gland to secrete the hormone thyroxine (T4), which has only a slight effect on metabolism. T4 is converted to triiodothyronine (T3), which is the active hormone that stimulates metabolism. About 80% of this conversion is in the liver and other organs, and 20% in the thyroid itself. TSH is secreted throughout life but particularly reaches high levels during the periods of rapid growth and development, as well as in response to stress. The hypothalamus, in the base of the brain, produces thyrotropin-releasing hormone (TRH). TRH stimulates the anterior pituitary gland to produce TSH. Somatostatin is also produced by the hypothalamus, and has an opposite effect on the pituitary production of TSH, decreasing or inhibiting its release. The concentration of thyroid hormones (T3 and T4) in the blood regulates the pituitary release of TSH; when T3 and T4 concentrations are low, the production of TSH is increased, and, conversely, when T3 and T4 concentrations are high, TSH production is decreased. This is an example of a negative feedback loop. Any inappropriateness of measured values, for instance a low-normal TSH together with a low-normal T4 may signal tertiary (central) disease and a TSH to TRH pathology. Elevated reverse T3 (RT3) together with low-normal TSH and low-normal T3, T4 values, which is regarded as indicative for euthyroid sick syndrome, may also have to be investigated for chronic subacute thyroiditis (SAT) with output of subpotent hormones.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.